Arete Wealth Advisors’s Allergan plc AGN Stock Holding History

Arete Wealth Advisors’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-1,346	Closed	-$220K	–	355
2017 Q4	$220K	Buy	+1,346	New	+$242K	0.07%	282

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Arete Wealth Advisors's AGN Position: Q1 2018 in Review

Arete Wealth Advisors sold out of Allergan plc (AGN) in Q1 2018, closing a stake of 1,346 shares — an estimated $220K sold.

Arete Wealth Advisors first reported a position in AGN in Q4 2017 and held it in 1 quarter. The position peaked at $220K in Q4 2017. 1,022 funds tracked by Wall St. Rank hold AGN as of Q1 2018.

Arete Wealth Advisors reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
Arete Wealth Advisors sold 1,346 Allergan plc shares in Q1 2018, an estimated $220K.
Arete Wealth Advisors first reported a position in Allergan plc in Q4 2017 and held it in 1 quarter.
Arete Wealth Advisors's Allergan plc position peaked at $220K in Q4 2017.
1,022 funds tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Arete Wealth Advisors's 13F filing for Q1 2018, filed 15 May 2018.